Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Guidance is provided in a European setting on the assessment and treatment of postmenopausal women at risk of fractures due to osteoporosis.The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2008. This manuscript updates these in a European setting.Systematic literature reviews.The following areas are reviewed: the role of bone mineral density measurement for the diagnosis of osteoporosis and assessment of fracture risk, general and pharmacological management of osteoporosis, monitoring of treatment, assessment of fracture risk, case finding strategies, investigation of patients and health economics of treatment.A platform is provided on which specific guidelines can be developed for national use.

Original publication

DOI

10.1007/s00198-012-2074-y

Type

Journal article

Journal

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Publication Date

01/2013

Volume

24

Pages

23 - 57

Addresses

WHO Collaborating Centre, UK University of Sheffield Medical School, Sheffield, UK. w.j.pontefract@sheffield.ac.uk

Keywords

Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF), Humans, Osteoporosis, Postmenopausal, Hip Fractures, Absorptiometry, Photon, Drug Monitoring, Risk Assessment, Age Distribution, Bone Density, Aged, Aged, 80 and over, Middle Aged, Europe, Female, Bone Density Conservation Agents, Medication Adherence, Osteoporotic Fractures, Biomarkers